Tempest Therapeutics Inc.

NASDAQ: TPST · Real-Time Price · USD
7.08
-0.07 (-0.98%)
At close: Jun 26, 2025, 3:59 PM
-0.98%
Bid 6.88
Market Cap 28.94M
Revenue (ttm) n/a
Net Income (ttm) -44.8M
EPS (ttm) -18.04
PE Ratio (ttm) -0.39
Forward PE -0.68
Analyst Hold
Ask 7.5
Volume 54,243
Avg. Volume (20D) 122,732
Open 7.04
Previous Close 7.15
Day's Range 7.04 - 7.13
52-Week Range 5.36 - 30.03
Beta -2.33

About TPST

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TPST
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for TPST stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
2 weeks ago
-15.88%
Tempest Therapeutics shares are trading lower afte... Unlock content with Pro Subscription
3 weeks ago
+15.07%
Tempest Therapeutics shares are trading higher after the company announced it received orphan drug designation from the EMA for its amezalpat for the treatment of patients with hepatocellular carcinoma